Status:
COMPLETED
PRospective Multicenter Observational Study on Transfusion Practice in Vv-ECMO Patients: The PROTECMO Study
Lead Sponsor:
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Collaborating Sponsors:
Medical University of Vienna
University of Maryland, College Park
Conditions:
Extracorporeal Membrane Oxygenation Complication
Transfusion Related Complication
Eligibility:
All Genders
18+ years
Brief Summary
Background: Over the past decade, the use of extracorporeal membrane oxygenation (ECMO) for respiratory support in adults has increased. Several trials have highlighted how red blood cells transfusion...
Detailed Description
Background Over the past decade, the use of extracorporeal Membrane Oxygnation (ECMO) for respiratory support in adults has vastly increased. Veno-venous ECMO (VV-ECMO) can be initiated in case of Acu...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- All consecutive patients who receive veno-venous ECMO for respiratory causes. Of note, considering the observational design of our study, patients can be included in other studies concurrently (this will be noted on the CRF).
- Exclusion criteria:
- \- Refusal to include expressed by the relatives when tha patient is unconscious or by the patient when he is recovered.
Exclusion
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
656 Patients enrolled
Trial Details
Trial ID
NCT03815773
Start Date
December 1 2018
End Date
December 31 2020
Last Update
September 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ismett
Palermo, Italy, 90133